Expanding the sources of donor pool for pediatric liver transplantation

References:

[1] Goldaracena N, Echeverri J, Kehar M, et al. Pediatric living donor liver transplantation with large-for-size left lateral segment grafts[J]. Am J Transplant,2020, 20(2):504-512. DOI:10. 1111/ajt. 15609.
[2] Martinelli J, Habes D, Majed L, et al. Long-term outcome of liver transplantation in childhood:A study of 20-year survivors[J]. Am J Transplant, 2018, 18(7):1680-1689. DOI:10. 1111/ajt. 14626.
[3] Thalji L, Thalji NM, Heimbach JK, et al. Renal function parame- ters and serum sodium enhance prediction of wait-list outcomes in pediatric liver transplantation[J]. Hepatology, 2021, 73(3):1117-1131. DOI:10. 1002/hep. 31397.
[4] Song Z, Ma N, Dong C, et al. Feasibility and safety of using low- body-weight donors in pediatric liver transplantation[J]. J Pedi- atr Surg,2019,54(11):2382-2386. DOI:10. 1016/j. jpedsurg. 2019. 04. 023.
[5] Angelico R, Perera M, Manzia TM, et al. Donation after circulato- ry death in paediatric liver transplantation:current status and fu- ture perspectives in the machine perfusion era[J]. Biomed Res Int,2018,2018:1756069. DOI:10. 1155/2018/1756069.
[6] Hong JC, Venick R, Yersiz H, et al. Liver transplantation in chil- dren using organ donation after circulatory death:a case-control outcomes analysis of a 20-year experience in a single center[J]. JAMA Surg, 2014, 149(1):77-82. DOI:10. 1001/jamasurg. 2013. 3195.
[7] Watson C, Hunt F, Messer S, et al. In situ normothermic perfu- sion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival[J]. Am J Transplant, 2019, 19(6):1745-1758. DOI:10. 1111/ajt. 15241.
[8] Vogel T, Brockmann JG, Quaglia A, et al. The 24-hour normo- thermic machine perfusion of discarded human liver grafts[J]. Liver Transpl,2017,23(2):207-220. DOI:10. 1002/lt. 24672.
[9] Sun C, Song Z, Ma N, et al. The management and outcomes of ABO-incompatible pediatric liver transplantation:Experience of a single Chinese center[J]. J Pediatr Surg, 2020, 55(12):2647-2652. DOI:10. 1016/j. jpedsurg. 2020. 01. 059.
[10] Okada N, Sanada Y, Hirata Y, et al. The impact of rituximab in ABO-incompatible pediatric living donor liver transplantation:the experience of a single center[J]. Pediatr Transplant, 2015, 19(3):279-286. DOI:10. 1111/petr. 12445.
[11] Dong C, Gao W, Ma N, et al. Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation[J]. Pediatr Trans- plant,2017,21(2). DOI:10. 1111/petr. 12854.
[12] EASL Clinical Practice Guidelines:Liver transplantation[J]. J Hepatol,2016,64(2):433-485. DOI:10. 1016/j. jhep. 2015. 10. 006.
[13] 中华医学会感染病学分会, 中华医学会肝病学分会. 慢性乙型肝炎防治指南(2019年版)[J]. 中华传染病杂志,2019,37(12):711-736. DOI:10. 3760/cma. j. issn. 1007-3418. 2019. 12. 007. Chinese Societies of Infectious Diseases and Hepatology, Chinese Medical Association:Guidelines of Prevention & Treatment for Chronic Hepatitis B (2019 version)[J]. Chinese Journal of Hep- atology,2019, 37(12):711-736. DOI:10. 3760/cma. j. issn. 1007-3418. 2019. 12. 007.
[14] 董冲, 高伟, 马楠, 等. 乙型肝炎核心抗体阳性亲属活体供肝应用于儿童受者的风险及治疗方案[J]. 中华器官移植杂志, 2015,36(2):92-96. DOI:10. 3760/cma. j. issn. 0254-1785. 2015. 02. 007. Dong C, Gao W, Ma N, et al. De novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver trans- plantation and the treatment[J]. Chinese Journal of Organ Trans- plantation,2015,36(2):92-96. DOI:10. 3760/cma. j. issn. 0254-1785. 2015. 02. 007.
[15] Dong C, Song Z, Chen J, et al. Risk factors of de novo hepatitis B virus infection in pediatric hepatitis B core antibody positive liver graft recipients under prophylactic therapy[J]. J Gastroenterol Hepatol,2020,35(5):827-832. DOI:10. 1111/jgh. 14869.
[16] Irie R, Nakazawa A, Sakamoto S, et al. Outcome for pediatric re- cipients of macrosteatotic liver grafts from living donors[J]. Liver Transpl,2020,26(7):899-905. DOI:10. 1002/lt. 25784.
[17] Strong RW, Lynch SV, Ong TH, et al. Successful liver transplanta- tion from a living donor to her son[J]. N Engl J Med,1990,322(21):1505-1507. DOI:10. 1056/NEJM199005243222106.
[18] Kasahara M, Umeshita K, Sakamoto S, et al. Living donor liver transplantation for biliary atresia:An analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society[J]. Am J Transplant,2018,18(3):659-668. DOI:10. 1111/ajt. 14489.
[19] Miller CM, Quintini C, Dhawan A, et al. The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline[J]. Transplantation, 2017, 101(5):938-944. DOI:10. 1097/TP. 0000000000001571.
[20] Squires RH, Ng V, Romero R, et al. Evaluation of the pediatric patient for liver transplantation:2014 Practice Guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pe- diatric Gastroenterology, Hepatology and Nutrition[J]. Hepatolo- gy,2014,60(1):362-398. DOI:10. 1002/hep. 27191.
[21] Hong SK, Suh KS, Kim KA, et al. Pure laparoscopic versus open left hepatectomy including the middle hepatic vein for living donor liver transplantation[J]. Liver Transpl, 2020, 26(3):370-378. DOI:10. 1002/lt. 25697.
[22] Troisi RI, Elsheikh Y, Alnemary Y, et al. Safety and feasibility re- port of robotic-assisted left lateral sectionectomy for pediatric liv- ing donor liver transplantation:a comparative analysis of learning curves and mastery achieved with the laparoscopic approach[J]. Transplantation, 2021, 105(5):1044-1051. DOI:10. 1097/TP. 0000000000003332.
[23] Pichlmayr R, Ringe B, Gubernatis G, et al. Transplantation of a donor liver to 2 recipients (splitting transplantation) -a new meth- od in the further development of segmental liver transplantation[J]. Langenbecks Arch Chir,1988,373(2):127-130.
[24] Renz JF, Yersiz H, Reichert PR, et al. Split-liver transplantation:a review[J]. Am J Transplant, 2003, 3(11):1323-1335. DOI:10. 1046/j. 1600-6135. 2003. 00254. x.
[25] Busuttil RW, Goss JA. Split liver transplantation[J]. Ann Surg, 1999,229(3):313-321. DOI:10. 1097/00000658-199903000-00003.
[26] Gao W, Song Z, Ma N, et al. Application of pediatric donors in split liver transplantation:Is there an age limit?[J]. Am J Transplant,2020,20(3):817-824. DOI:10. 1111/ajt. 15641.
[27] Furtado A, Tomé L, Oliveira FJ, et al. Sequential liver transplanta- tion[J]. Transplant Proc, 1997, 29(1-2):467-468. DOI:10. 1016/s0041-1345(96) 00206-0.
[28] Marques HP, Barros I, Li J, et al. Current update in domino liver transplantation[J]. Int J Surg, 2020, 82S:163-168. DOI:10. 1016/j. ijsu. 2020. 03. 017.
[29] Celik N, Squires JE, Soltys K, et al. Domino liver transplantation for select metabolic disorders:Expanding the living donor pool[J]. JIMD Rep,2019,48(1):83-89. DOI:10. 1002/jmd2. 12053.
[30] Shimizu S, Sakamoto S, Fukuda A, et al. Surgical technique and the long-term outcomes of pediatric living donor domino liver transplantation from patients with maple syrup urine disease[J]. Pediatr Transplant, 2022, 26(2):e14174. DOI:10. 1111/petr. 14174.
[31] Dong C, Song Z, Meng X, et al. Successful living donor liver trans- plantation plus domino-auxiliary partial orthotopic liver transplan- tation for pediatric patients with metabolic disorders[J]. Pediatr Surg Int,2020,36(12):1443-1450. DOI:10. 1007/s00383-020-04756-3.
[32] Qu W, Wei L, Zhu ZJ, et al. Considerations for use of domino cross-auxiliary liver transplantation in metabolic liver diseases:a review of case studies[J]. Transplantation,2019,103(9):1916-1920. DOI:10. 1097/TP. 0000000000002602.
[33] 张国锋, 董冲, 孙超, 等. 儿童减体积左外叶活体肝移植疗效的回顾性分析[J]. 中华器官移植杂志, 2021, 42(11):657-662. DOI:10. 3760/cma. j. cn421203-20210330-00117. Zhang GF, Dong C, Sun C, et al. Efficacy analysis of reduced left lateral segment graft during pediatric living donor liver transplan- tation[J]. Chinese Journal of Organ Transplantation, 2021, 42(11):657-662. DOI:10. 3760/cma. j. cn421203-20210330-0011 7.
[34] Sakamoto S, Sasaki K, Uchida H, et al. A severely cholestatic liver graft can be successfully used in deceased donor liver transplanta- tion[J]. Hepatol Res,2018,48(3):E367-E371. DOI:10. 1111/hepr. 12968.
[35] de la Villa S, Valerio M, Salcedo M, et al. Heart and liver trans- plant recipients from donor with positive SARS-CoV-2 RT-PCR at time of transplantation[J]. Transpl Infect Dis, 2021, 23(5):e13664. DOI:10. 1111/tid. 13664.